Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Perceptive Life Sciences Master Fund Ltd
Relationship:   10% Owner
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   12    
Direct Shares   2,270,404    

Indirect Shares

   99,979,160      
Direct Value   $1,366,783    

Indirect Value

   $321,937,176      
Total Shares   102,249,564      
Total Value   $323,303,959      


VBI Vaccines Inc $1,366,783 VBI Vaccines Inc $1,366,783
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Penwest Pharmaceuticals Co PPCO 10% Owner 2008-09-29 0 2008-10-24 6,422,846    Premium*  
            XTL Biopharmaceuticals Ltd XTLBY 10% Owner 2008-11-19 0 2008-11-19 20,580,260    Premium*  
            Optimer Pharmaceuticals Inc OPTR 10% Owner 2008-07-02 0 2008-07-02 113,442    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2011-07-01 26,666,667    Premium*  
            Aegerion Pharmaceuticals, Inc. AEGR 10% Owner 2012-12-04 0 2013-09-05 2,823,426    Premium*  
            Acelrx Pharmaceuticals Inc ACRX 10% Owner 2013-07-23 0 2016-09-29 5,386,410    Premium*  
            Amicus Therapeutics Inc FOLD 10% Owner 2014-06-30 0 2016-12-30 16,293,847    Premium*  
            VBI Vaccines Inc VBIV 10% Owner 2014-07-25 2,270,404 2016-12-06 6,213,314    Premium*  
            Aldeyra Therapeutics, Inc. ALDX 10% Owner 2015-10-20 0 2017-02-14 2,589,451    Premium*  
            Aravive Inc ARAV 10% Owner 2016-12-29 0 2017-02-13 4,228,563    Premium*  
            Corium International, Inc. CORI 10% Owner 2017-05-25 0 2017-05-25 5,546,129    Premium*  
            Athira Pharma, Inc. ATHA 10% Owner 0 2020-09-22 3,114,805    Premium*  
* Premium Members only  

Records found :    62         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ACRX Acelrx Pharmaceuticals In... 10% Owner   –       –       •   2013-07-23 4 B $11.65 $9,902,500 I/I 850,000 5,858,400 1.5 -
ACRX Acelrx Pharmaceuticals In... 10% Owner   –       –       •   2013-10-31 4 B $6.69 $1,338,640 I/I 200,000 6,058,400 1.5 -
ACRX Acelrx Pharmaceuticals In... 10% Owner   –       –       •   2013-11-01 4 B $7.17 $1,151,900 I/I 160,660 6,219,060 1.5 -
ACRX Acelrx Pharmaceuticals In... 10% Owner   –       –       •   2013-11-04 4 B $6.84 $1,064,292 I/I 155,000 6,374,060 1.5 -
ACRX Acelrx Pharmaceuticals In... 10% Owner   –       –       •   2013-11-06 4 B $6.52 $651,660 I/I 100,000 6,474,060 1.5 -
ACRX Acelrx Pharmaceuticals In... 10% Owner   –       –       •   2013-11-07 4 B $6.50 $649,810 I/I 100,000 6,574,060 1.5 -
ACRX Acelrx Pharmaceuticals In... 10% Owner   –       –       •   2015-09-09 4 S $4.18 $1,294,777 I/I (310,000) 6,264,060 0 -
ACRX Acelrx Pharmaceuticals In... 10% Owner   –       –       •   2015-11-05 4 S $4.62 $346,260 I/I (75,000) 6,189,060 0 -
ACRX Acelrx Pharmaceuticals In... 10% Owner   –       –       •   2015-11-06 4 S $4.47 $76,365 I/I (17,100) 6,171,960 0 -
ACRX Acelrx Pharmaceuticals In... 10% Owner   –       –       •   2015-11-17 4 S $5.36 $717,409 I/I (133,900) 6,038,060 0 -
ACRX Acelrx Pharmaceuticals In... 10% Owner   –       –       •   2015-11-18 4 S $5.35 $226,132 I/I (42,300) 5,995,760 0 -
ACRX Acelrx Pharmaceuticals In... 10% Owner   –       –       •   2016-09-15 4 S $3.63 $1,452,811 I/I (392,850) 5,602,910 0 -
ACRX Acelrx Pharmaceuticals In... 10% Owner   –       –       •   2016-09-28 4 S $3.96 $472,380 I/I (119,300) 5,483,610 0 -
ACRX Acelrx Pharmaceuticals In... 10% Owner   –       –       •   2016-09-29 4 S $3.88 $377,117 I/I (97,200) 5,386,410 0 -
AEGR Aegerion Pharmaceuticals,... 10% Owner   –       –       •   2012-12-04 4 B $21.27 $425,400 I/I 20,000 2,615,293 1.5 -
AEGR Aegerion Pharmaceuticals,... 10% Owner   –       –       •   2013-01-11 4 B $26.64 $12,857,220 I/I 475,000 3,223,426 1.5 -
AEGR Aegerion Pharmaceuticals,... 10% Owner   –       –       •   2013-01-17 4 B $26.73 $1,336,285 I/I 50,000 3,273,426 1.5 -
AEGR Aegerion Pharmaceuticals,... 10% Owner   –       –       •   2013-01-18 4 B $27.62 $1,381,000 I/I 50,000 3,323,426 1.5 -
AEGR Aegerion Pharmaceuticals,... 10% Owner   –       –       •   2013-02-01 4 B $27.79 $1,389,400 I/I 50,000 3,373,426 1.5 -
AEGR Aegerion Pharmaceuticals,... 10% Owner   –       –       •   2013-06-15 4 OE $25.00 $5,000,000 I/I 200,000 3,573,426 0 -
AEGR Aegerion Pharmaceuticals,... 10% Owner   –       –       •   2013-09-05 4 S $89.20 $66,900,000 I/I (750,000) 2,823,426 0 -
ALDX Aldeyra Therapeutics, Inc... 10% Owner   –       –       •   2015-10-20 4 B $6.30 $237,193 I/I 37,145 1,127,338 1.5 -
ALDX Aldeyra Therapeutics, Inc... 10% Owner   –       –       •   2015-10-22 4 B $6.47 $116,661 I/I 18,020 1,145,358 1.5 -
ALDX Aldeyra Therapeutics, Inc... 10% Owner   –       –       •   2015-10-26 4 B $6.46 $323,150 I/I 50,000 1,195,358 1.5 -
ALDX Aldeyra Therapeutics, Inc... 10% Owner   –       –       •   2015-10-28 4 B $6.50 $293,150 I/I 45,100 1,240,458 1.5 -
  62  Records found
  1  2   3      
  Page 1 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us